Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,199 | 40 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $216.82 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $198.02 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $144.88 | 3 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $129.31 | 4 | $0 (2024) |
| Neurelis, Inc. | $101.00 | 1 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $83.81 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $61.46 | 3 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $55.00 | 2 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $43.67 | 2 | $0 (2024) |
| Amgen Inc. | $32.33 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $751.73 | 29 | Novartis Pharmaceuticals Corporation ($181.86) |
| 2023 | $446.81 | 11 | AstraZeneca Pharmaceuticals LP ($216.82) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $24.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $42.10 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $105.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: Not Applicable | ||||||
| 10/24/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $16.97 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: Not Applicable | ||||||
| 08/26/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Genetic Disease | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Genetic Disease | ||||||
| 06/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $90.21 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.61 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/18/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $24.74 | General |
| Category: Cardiology | ||||||
| 03/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/07/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $101.00 | General |
| Category: EPILEPSY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 173 | 207 | $16,205 | $9,605 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 109 | 140 | $13,680 | $8,584 | 62.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 19 | $1,325 | $767.50 | 57.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 45 | 48 | $1,200 | $253.44 | 21.1% |
About Molly Peck
Molly Peck is a Critical Care Medicine healthcare provider based in Covington, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2021. The National Provider Identifier (NPI) number assigned to this provider is 1548849680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Molly Peck has received a total of $1,199 in payments from pharmaceutical and medical device companies, with $751.73 received in 2024. These payments were reported across 40 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,199).
As a Medicare-enrolled provider, Peck has provided services to 173 Medicare beneficiaries, totaling 207 services with total Medicare billing of $9,605. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Acute Care
- Location Covington, LA
- Active Since 04/06/2021
- Last Updated 04/06/2021
- Taxonomy Code 363LC0200X
- Entity Type Individual
- NPI Number 1548849680
Products in Payments
- LEQVIO (Drug) $198.02
- LifeVest (Device) $129.31
- CAMZYOS (Drug) $127.63
- FARXIGA (Drug) $116.82
- VALTOCO (Drug) $101.00
- ANDEXXA (Biological) $100.00
- Assure WCD (Device) $83.81
- XARELTO (Drug) $61.46
- Arcalyst (Drug) $55.00
- ONPATTRO (Drug) $43.67
- ELIQUIS (Drug) $33.95
- Repatha (Biological) $32.33
- JARDIANCE (Drug) $26.82
- Impella (Device) $24.08
- WINREVAIR (Biological) $18.18
- FUROSCIX (Drug) $16.40
- LINQ II (Device) $15.26
- NEXLETOL (Drug) $14.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Covington
Ricardo Blanco, M.d, M.D
Critical Care Medicine — Payments: $18,743
Richard Casey, M.d, M.D
Critical Care Medicine — Payments: $11,622
David Cressy, D.o, D.O
Critical Care Medicine — Payments: $10,239
Tracy Aljabi, Fnp, FNP
Critical Care Medicine — Payments: $6,578
Kendol Thomas, M.d, M.D
Critical Care Medicine — Payments: $3,818
Donald Kuebel, M.d, M.D
Critical Care Medicine — Payments: $1,698